Reemergence of monkeypox: Prevalence, diagnostics, and countermeasures

Clinical Infectious Diseases

Volumn 41, Issue 12, 2005, Pages 1765-1771

  Nalca, Aysegul ^a   Rimoin, Anne W ^b   Bavari, Sina ^a   Whitehouse, Chris A ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; BIOLOGICAL WARFARE; FLU LIKE SYNDROME; HUMAN; INFECTION PREVENTION; MONKEYPOX; MONKEYPOX VIRUS; PREVALENCE; PRIORITY JOURNAL; RAIN FOREST; REVIEW; SMALLPOX; VACCINATION; VIRUS INFECTION; ZOONOSIS;

ANIMALS; COMMUNICABLE DISEASES, EMERGING; DISEASE OUTBREAKS; HUMANS; MONKEYPOX; PREVALENCE;

EID: 28744431693     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/498155     Document Type: Review

References (45)

1. Khodakevich L, Jezek Z, Messinger D. Monkeypox virus: ecology and public health significance. Bull World Health Organ 1988; 66:747-52.
2. Breman JG, Kalisa R, Steniowski MV, Zanotto E, Gromyko AI, Arita I. Human monkeypox, 1970-79. Bull World Health Organ 1980;58:165-82.
3. The global eradication of smallpox: final report of the global commission for the certification of smallpox eradication. Geneva, Switzerland: World Health Organization, 1980.
4. Jezek Z, Fenner F. Human monkeypox. In: Melnick IL, ed. Monographs in virology. Vol. 17. Basel, Switzerland: Karger, 1988.
5. Jezek Z, Arita I, Mutombo M, Dunn C, Nakano JH, Szczeniowski M. Four generations of probable person-to-person transmission of human monkeypox. Am J Epidemiol 1986; 123:1004-12.
6. Heymann DL, Szczeniowski M, Esteves K. Re-emergence of monkeypox in Africa: a review of the past six years. Br Med Bull 1998;54:693-702.
7. Hutin YJ, Williams RJ, Malfait P, et al. Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. Emerg Infect Dis 2001;7:434-8.
8. Kebela B. Le profil epidemiologique de monkeypox en RDC 1998-2002. Bulletin Epidemiologique de la Republique Democratique du Congo 2004; 29:2-6.
9. Reed KD, Melski JW, Graham MB, et al. The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med 2004; 350:342-50.
10. Multistate outbreak of monkeypox-Illinois, Indiana, and Wisconsin, 2003. MMWR Morb Mortal Wkly Rep 2003; 52:537-40.
11. Sejvar JJ, Chowdary Y, Schomogyi M, et al. Human monkeypox infection: a family cluster in the midwestern United States. J Infect Dis 2004; 190:1833-40.
12. Update: multistate outbreak of monkeypox-Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. MMWR Morb Mortal Wkly Rep 2003; 52:642-6.
13. Fleischauer AT, Kile JC, Davidson M, et al. Evaluation of human-to-human transmission of monkeypox from infected patients to health care workers. Clin Infect Dis 2005; 40:689-94.
14. Update: multistate outbreak of monkeypox-Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. MMWR Morb Mortal Wkly Rep 2003; 52:589-90.
15. Anderson MG, Frenkel LD, Homann S, Guffey J. A case of severe monkeypox virus disease in an American child: emerging infections and changing professional values. Pediatr Infect Dis J 2003; 22:1093-6.
16. Jezek Z, Szczeniowski M, Paluku KM, Mutombo M. Human monkeypox: clinical features of 282 patients. J Infect Dis 1987; 156:293-8.
17. Cehn N, Guiyun L, Liszewski MK, et al. Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology 2005; 340:46-63.
18. Foster SO, Brink EW, Hutchins DL, et al. Human monkeypox. Bull World Health Organ 1972; 46:569-76.
19. Ladnyj ID, Ziegler P, Kima E. A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. Bull World Health Organ 1972; 46:593-7.
20. Human monkeypox and other poxvirus infections of man. In: Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID, eds. Smallpox and its eradication. Vol. 29. Geneva, Switzerland: World Health Organization, 1988:1287-319.
21. Di Giulio DB, Eckburg PB. Human monkeypox: an emerging zoonosis. Lancet Infect Dis 2004; 4:15-25.
22. Frey SE, Belshe RB. Poxvirus zoonoses-putting pocks into context. N Engl J Med 2004; 350:324-7.
23. Bayer-Garner IB. Monkeypox virus: histologic, immunohistochemical and electron-microscopic findings. J Cutan Pathol 2005; 32:28-34.
24. Gentile M, Gelderblom HR. Rapid viral diagnosis: role of electron microscopy. New Microbiol 2005; 28:1-12.
25. Damon IK, Esposito JJ. Poxviruses that infect humans. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolker MH, eds. Manual of clinical microbiology. 8th ed. Washington, DC: ASM Press, 2003:1583-91.
26. Olson VA, Laue T, Laker MT, et al. Real-time PCR system for detection of orthopoxviruses and simultaneous identification of smallpox virus. J Clin Microbiol 2004; 42:1940-6.
27. Kulesh DA, Loveless BM, Norwood D, et al. Monkeypox virus detection in rodents using real-time 3′-minor groove binder TaqMan assays on the Roche LightCycler. Lab Invest 2004; 84:1200-8.
28. Lapa S, Mikheev M, Shchelkunov S, et al. Species-level identification of orthopoxviruses with an oligonucleotide microchip. J Clin Microbiol 2002; 40:753-7.
29. Jezek Z, Marennikova SS, Mutumbo M, Nakano JH, Paluku KM, Szczeniowski M. Human monkeypox: a study of 2510 contacts of 214 patients. J Infect Dis 1986; 154:551-5.
30. Fine PE, Jezek Z, Grab B, Dixon H. The transmission potential of monkeypox virus in human populations. Int J Epidemiol 1988; 17:643-50.
31. Arita I, Jezek Z, Khodakevich L, Ruti K. Human monkeypox: a newly emerged orthopoxvirus zoonosis in the tropical rain forests of Africa. Am J Trop Med Hyg 1985; 34:781-9.
32. McConnell S, Herman YF, Mattson DE, Huxsoll DL, Lang CM, Yager RH. Protection of rhesus monkeys against monkeypox by vaccinia virus immunization. Am J Vet Res 1964; 25:192-5.
33. Updated interim CDC guidance for use of smallpox vaccine, cidofovir, and vaccinia immune globin (VIG) for prevention and treatment in the setting of an outbreak of monkeypox infections. 25 June 2003. Available at: http://www.cdc.gov/ncidod/monkeypox/treatmentguidelines.htm. Accessed 4 April 2005.
34. Bray M. Pathogenesis and potential antiviral therapy of complications of smallpox vaccination. Antiviral Res 2003; 58:101-14.
35. Bray M, Wright ME. Progressive vaccinia. Clin Infect Dis 2003; 36:766-74.
36. Burnett JC, Henchal EA, Schmaljohn AL, Bavari S. The evolving field of biodefence: therapeutic developments and diagnostics. Nat Rev Drug Discov 2005; 4:281-97.
37. De Clercq E. Cidofovir in the treatment of poxvirus infections. Antiviral Res 2002; 55:1-13.
38. Smee DF, Bailey KW, Sidwell RW. Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir. Antivir Chem Chemother 2001; 12:71-6.
39. Smee DF, Bailey KW, Wong MH, Sidwell RW. Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice. Antiviral Res 2001; 52:55-62.
40. Neyts J, De Clercq E. Efficacy of (S)-1-(3-hydroxy-2- phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice. J Med Virol 1993; 41:242-6.
41. Bray M, Martinez M, Smee DF, Kefauver D, Thompson E, Huggins JW. Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge. J Infect Dis 2000; 181:10-9.
42. Smee DF, Bailey KW, Wong M, Sidwell RW. Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir. Antiviral Res 2000; 47:171-7.
43. Quenelle DC, Collins DJ, Wan WB, Beadle JR, Hostetler KY, Kern ER. Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir. Antimicrob Agents Chemother 2004; 48:404-12.
44. De Clercq E. Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections. Clin Microbiol Rev 2001; 14:382-97.
45. Baker RO, Bray M, Huggins JW. Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Antiviral Res 2003; 57:13-23.